Sign in
Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis
Journal article   Peer reviewed

Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis

Tracey G Simon, Maria Esther Perez Trejo, Robyn McClelland, Ryan Bradley, Michael J Blaha, Irfan Zeb, Kathleen E Corey, Matthew J Budoff and Raymond T Chung
International journal of cardiology, Vol.259, pp.198-204
15/05/2018
PMCID: PMC5875712
PMID: 29579601

Metrics

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Abstract

Atherosclerosis Biomarker Cardiovascular disease Fatty liver Inflammation Nonalcoholic fatty liver disease

Details